Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
1.285
-0.145 (-10.14%)
Mar 9, 2026, 2:37 PM EDT - Market open
Nuwellis Revenue
Nuwellis had revenue of $2.22M in the quarter ending September 30, 2025, a decrease of -6.34%. This brings the company's revenue in the last twelve months to $8.17M, down -8.93% year-over-year. In the year 2024, Nuwellis had annual revenue of $8.74M, down -1.40%.
Revenue (ttm)
$8.17M
Revenue Growth
-8.93%
P/S Ratio
0.33
Revenue / Employee
$214,947
Employees
38
Market Cap
2.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
| Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
| Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
| Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
| Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| INVO Fertility | 6.94M |
| Biomerica | 4.46M |
| Intelligent Bio Solutions | 3.58M |
| ENvue Medical | 2.69M |
| Catheter Precision | 730.00K |
| Tivic Health Systems | 482.00K |
| iTonic Holdings | 305.22K |
NUWE News
- 4 days ago - Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy - GlobeNewsWire
- 11 days ago - Nuwellis Appoints David A. McDonald and Martin J. - GlobeNewsWire
- 13 days ago - Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - GlobeNewsWire
- 5 weeks ago - Nuwellis Appoints Carisa Schultz as Chief Financial Officer - GlobeNewsWire
- 5 weeks ago - Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market - GlobeNewsWire
- 5 weeks ago - Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy - GlobeNewsWire
- 5 weeks ago - Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare - Benzinga
- 6 weeks ago - Nuwellis Announces Changes to Board of Directors - GlobeNewsWire